BioSpace News Archive

Outset Medical, Inc. is presenting five new abstracts providing promising insights on the clinical and financial benefits of home hemodialysis, gender biases toward female nephrologists and other pertinent topics related to kidney disease.

Reaction Biology (“Reaction” or the “Company”) today announced that eleven abstracts highlighting data from the Company’s expanding suite of research offerings will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, held April 14-19, 2023, in Orlando, Florida.

Altamira Therapeutics (“Altamira” or the “Company”) (Nasdaq:CYTO) today announced the publication of the detailed results from its TRAVERS Phase 2 trial with AM-125 (intranasal betahistine) in surgery-induced acute vestibular syndrome (AVS).

Panavance Therapeutics Inc. announced that Greg Bosch, Chairman and CEO of Panavance Therapeutics will present at BioNJ’s Thirteenth Annual BioPartnering Conference on Tuesday, April 18, 2023 at 10:20 AM ET in Somerset, NJ.

CancerVAX, Inc. reported that CEO Ryan Davies spoke about the importance of cancer immunotherapy with Dr. Satiro De Oliveira, a principal investigator in the Company’s cancer research program at UCLA.

Initial offerings focus on high-content imaging and digital PCR Agathos Biologics, a leading biotechnology company, is proud to offer advanced analytical testing services for life science researchers.

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that it will present an overview of the company at the 22nd Annual Needham Virtual Healthcare Conference.

Allegro Ophthalmics, LLC today announced that the Company has received agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for the design of its Phase 2b/3 clinical trial of risuteganib (Luminate®) for the treatment of intermediate, non-exudative age-related macular degeneration (dry AMD).

Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, recently had the results of a real-world analysis of Nerivio® for acute treatment of migraine in adolescents published in the journal Pediatric Neurology.

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that the Board of Directors has proposed Ms.